Results for search "Nose Bleeds".
More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.
Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without serious bleeding episodes for at least a year, according to results published Dec. 9 in
"Where Personal Service is the MOST Powerful Medicine" We're BIG in prescriptions!
2025 © All Rights Reserved. Privacy Policy
